Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124
Section 19
Definition of submission
Cite as Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124, s. 19 · current to July 24, 2025 · regulation last amended May 31, 2025
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
In this Division, submission means any of the following:
(a) an application for a drug identification number that is filed under section C.01.014.1 of the Food and Drug Regulations;
(b) a notification that is filed under subsection C.01.615(1) of those Regulations in respect of a veterinary health product;
(c) a new drug submission that is filed under section C.08.002 of those Regulations;
(d) an abbreviated new drug submission that is filed under section C.08.002.1 of those Regulations;
(e) a supplement to a new drug submission or an abbreviated new drug submission that is filed under section C.08.003 of those Regulations;
(f) a preclinical submission that is filed under subsection C.08.005(1) of those Regulations;
(g) information that is filed under section C.08.010 of those Regulations for the purpose of obtaining a letter of authorization;
(h) information and material that is filed under section C.08.014 of those Regulations for the purpose of obtaining an experimental studies certificate;
(i) information and material that is filed with the Minister in respect of a notifiable change; or
(j) a protocol that is filed with the Minister and may support any of the matters referred to in paragraphs (c) to (f) or (h).
Read the Fees in Respect of Drugs and Medical Devices Order on the Justice Laws Website ↗
Made under Food and Drugs Act, R.S.C. 1985, c. F-27.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.